Boehringer Ingelheim, Gubra Enter Third Obesity Deal

New pact builds on duo’s R&D activities begun in 2017

 
• By Sten Stovall
  
Examining Patient Obesity
Collaboration will further explore peptides and the gut-brain axis • Source: Shutterstock

More from Business

More from Scrip